Skip to main content
. 2021 May 30;13(11):2700. doi: 10.3390/cancers13112700
PTA Percutaneous Thermal Ablation
HCC Hepatocellular Carcinoma
BCLC Barcelona Clinic Liver Cancer
US Ultrasonography
RFS Recurrence-Free Survival
AFP Alpha-Fetoprotein
OS Overall Survival
MELD Model for End-Stage Liver Disease
NAFLD Non-Alcoholic Fatty Liver Disease
ECOG Eastern Cooperative Oncology Group
AASLD American Association for the Study of Liver Disease
EASL European Association for the Study of the Liver
BMI Body Mass Index
ALBI Albumin–Bilirubin
MRI Magnetic Resonance Imaging
ASA American Society of Anesthesiologists
CT Computed Tomography
SIR Society of Interventional Radiology
LTP Local tumor progression
SD Standard Deviation
IQR Interquartile Range
AIC Akaike Information Criterion
TACE Transarterial Chemoembolization
OR Odds Ratio
CI Confidence Interval
HR Hazard Ratio
NASH Non-Alcoholic Steatohepatitis